tirzepatide in hfpef Has Scaled the HFpEF/Obesity SUMMIT? Tirzepatide for Heart Failure with

doi:10.1016/j.cmet.2024.12.010 Corb Aron RA, Abid A, Vesa CM, et al

Tirzepatide and anxiety is a topic that comes up frequently in patient communities

It shows why the combination question needs medical context

Emerging hypotheses also suggest a possible role in reducing lymphedema risk in breast surgery patients undergoing axillary lymph node dissection, with or without immediate lymphatic reconstruction, by preventing obesity-induced mechanical pressure on lymphatic vessels [105]

The DAPA-CKD trial15 primary outcome was a composite of sustained decline in the eGFR of at least 50%, the onset of end-stage kidney disease, or death from either renal or CV causes

Timing: subcutaneous injection based on preclinical administration models